As of December 2025 ArriVent BioPharma has a market cap of โน91.50 Billion. This makes ArriVent BioPharma the world's 5931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 9th, 2025 the market cap of ArriVent BioPharma was reported to be: